Latest Shareholder Dilution News

Galilee Energy has finished construction of the Zydeco-1 drilling site in Louisiana, setting the stage for drilling to commence in early July 2026. The well targets a substantial 13.7 billion cubic feet of gas and 610,000 barrels of condensate, underpinning the company’s US Gulf Coast growth ambitions.

Tungsten Mining NL's Watershed Preliminary Economic Evaluation reveals a robust project with a pre-tax NPV of A$1.3 billion and a swift payback, aiming for first production by 2027 amid tightening global tungsten supply.

International Graphite Ltd (ASX:IG6) has partnered with Alkeemia S.p.A. to establish a graphite processing facility in Italy, aiming for first production in the second half of 2027 and a final investment decision by Q3 2026.

Racura Oncology has raised $34.3 million through shareholder-backed initiatives, securing funding for its lead asset RC220’s clinical trials in AML, EGFRm lung cancer, and cardioprotection in solid tumour patients.

Caravel Minerals secures an additional $15 million royalty funding from Regal Resources, doubling the funder's investment to $30 million and extending an existing loan facility to 2028.

Thor Energy’s latest soil air geochemistry survey at its HY-Range Project in South Australia has recorded natural hydrogen concentrations up to 3%, far surpassing previous readings and validating key exploration areas ahead of a major seismic survey.

InFocus Group Holdings is streamlining its software development operations by divesting Prodigy9 and consolidating under Onify, aiming for immediate cost savings and a leaner, AI-native delivery model.

Tivan Limited has locked in a minimum $15 million funding package through a $10 million option underwriting agreement and a $5 million share placement with strategic investor ETFS Capital, supporting accelerated development across its Australian and Timor-Leste projects.

4DMedical has leapfrogged into the European lung health market by acquiring Austrian AI imaging firm contextflow, gaining immediate commercial presence and a CE-marked lung cancer screening solution.

Bass Oil Limited offers up to 24 million free attaching options to recent placement participants, alongside nearly 8 million options to its lead manager PAC Partners, with no new funds raised from the options issue.

Novo Resources Corp has closed Tranche 2 of its placement, raising approximately C$1.93 million and issuing options to joint lead managers and participants, while Northern Star retains a near 10% stake.

VRX Silica has kicked off a $6.23 million renounceable entitlement offer, underwritten to $2 million, to fund key development activities at its Arrowsmith North silica sand project including a strategic property purchase and engineering works.